C-JUN AND AMYLOID-INDUCED APOPTOSIS

C-JUN 和淀粉样蛋白诱导的细胞凋亡

基本信息

  • 批准号:
    2460666
  • 负责人:
  • 金额:
    $ 16.35万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-09-01 至 1999-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: Apoptosis is emerging as a type of cell death with characteristic morphology that contributes to neuronal loss during normal development and in pathologic situations, including Alzheimer disease (AD), Huntington disease, stroke and seizure. Despite increasing interest in the process, few details concerning the molecular mechanisms of neuronal apoptosis are known. We previously identified a temporal cascade of gene induction in sympathetic neurons undergoing apoptosis because of nerve growth factor (NGF) deprivation and showed that the protein product of one induced gene, c-Jun, was necessary for death. In cortical neurons, apoptosis induced by AD amyloid b-protein (Ab) treatment is accompanied by a genetic cascade that is strikingly similar to that identified previously, including a robust c-jun induction. Since (i) c-jun mRNA is induced during neuronal apoptosis initiated by either Ab-treatment or NGF deprivation, (ii) this c-jun mRNA appears to form functional c-Jun protein in both model systems, as discerned by the subsequent activation of "downstream" genes, and (iii) c-Jun is necessary for apoptosis after NGF deprivation, our current working hypothesis is that events which lead up to, modulate, and include the induction of c-jun are necessary for Ab-induced neuronal death. In pursuit of this hypothesis, we propose to (i) compare and contrast patterns of gene expression in neurons undergoing apoptosis as a result of Ab -treatment of NGF-deprivation; (ii) define the role of c-Jun in Ab -induced neuronal apoptosis by using microinjected, neutralizing antibodies and ectopic expression of a dominant negative form of c-Jun; (iii) elucidate the mechanism(s) leading to c-jun induction in Ab-treated neurons, with particular emphasis on the role of oxidative stress; (iv) explore a possible mechanism of c-Jun action by analyzing Ab -treated neurons for markers of cell cycle re-entry, including patterns of c-Jun heterodimer formation; (v) compare the patterns of neuronal apoptosis and "apoptotic" gene expression in AD and control brain tissue to discern whether this genetic cascade may contribute to neuronal loss in vivo. These studies will evaluate the hypotheses that Ab -induced neuronal death is critically dependent on altered gene expression, that oxidative stress is central to these genetic events, and that this genetic cascade may contribute to neuronal loss in vivo in AD. Hence, this work will further our long-term goals of elucidating the mechanisms underlying neuronal death, and, ultimately, identifying pharmacologic means to prevent this death.
细胞凋亡是一种新兴的细胞死亡类型

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Steven Estus其他文献

Steven Estus的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Steven Estus', 18)}}的其他基金

How does D2-CD33 reduce Alzheimer's disease risk?
D2-CD33 如何降低阿尔茨海默病风险?
  • 批准号:
    10038417
  • 财政年份:
    2020
  • 资助金额:
    $ 16.35万
  • 项目类别:
The surprising impact of APOE alleles on gut microbiome: does altering the microbiome reduce AD risk?
APOE 等位基因对肠道微生物组的惊人影响:改变微生物组是否可以降低 AD 风险?
  • 批准号:
    9783096
  • 财政年份:
    2018
  • 资助金额:
    $ 16.35万
  • 项目类别:
Translating CD33 genetic mechanism into a novel Alzheimers therapeutic
将 CD33 遗传机制转化为新型阿尔茨海默病治疗方法
  • 批准号:
    8696452
  • 财政年份:
    2014
  • 资助金额:
    $ 16.35万
  • 项目类别:
Translating CD33 genetic mechanism into a novel Alzheimers therapeutic
将 CD33 遗传机制转化为新型阿尔茨海默病治疗方法
  • 批准号:
    9251728
  • 财政年份:
    2014
  • 资助金额:
    $ 16.35万
  • 项目类别:
Translating CD33 genetic mechanism into a novel Alzheimers therapeutic
将 CD33 遗传机制转化为新型阿尔茨海默病治疗方法
  • 批准号:
    9038210
  • 财政年份:
    2014
  • 资助金额:
    $ 16.35万
  • 项目类别:
APOE RECEPTOR SPLICING, GENETICS, AND AD
APOE 受体剪接、遗传学和 AD
  • 批准号:
    7580202
  • 财政年份:
    2009
  • 资助金额:
    $ 16.35万
  • 项目类别:
LDLR Genetics, Splicing and AD Risk
LDLR 遗传学、剪接和 AD 风险
  • 批准号:
    7272847
  • 财政年份:
    2006
  • 资助金额:
    $ 16.35万
  • 项目类别:
LDLR Genetics, Splicing and AD Risk
LDLR 遗传学、剪接和 AD 风险
  • 批准号:
    7626369
  • 财政年份:
    2006
  • 资助金额:
    $ 16.35万
  • 项目类别:
LDLR Genetics, Splicing and AD Risk
LDLR 遗传学、剪接和 AD 风险
  • 批准号:
    7150191
  • 财政年份:
    2006
  • 资助金额:
    $ 16.35万
  • 项目类别:
LDLR Genetics, Splicing and AD Risk
LDLR 遗传学、剪接和 AD 风险
  • 批准号:
    7440187
  • 财政年份:
    2006
  • 资助金额:
    $ 16.35万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Effects of TNF-alpha and free radicals on apoptosis of bovine mamary epithlial cells
TNF-α和自由基对牛乳腺上皮细胞凋亡的影响
  • 批准号:
    155423-1998
  • 财政年份:
    2001
  • 资助金额:
    $ 16.35万
  • 项目类别:
    Discovery Grants Program - Individual
Effects of TNF-alpha and free radicals on apoptosis of bovine mamary epithlial cells
TNF-α和自由基对牛乳腺上皮细胞凋亡的影响
  • 批准号:
    155423-1998
  • 财政年份:
    2000
  • 资助金额:
    $ 16.35万
  • 项目类别:
    Discovery Grants Program - Individual
Effects of TNF-alpha and free radicals on apoptosis of bovine mamary epithlial cells
TNF-α和自由基对牛乳腺上皮细胞凋亡的影响
  • 批准号:
    155423-1998
  • 财政年份:
    1999
  • 资助金额:
    $ 16.35万
  • 项目类别:
    Discovery Grants Program - Individual
FREE RADICALS AND MITOCHONDRIA IN NEURONAL APOPTOSIS
神经元凋亡中的自由基和线粒体
  • 批准号:
    6126363
  • 财政年份:
    1998
  • 资助金额:
    $ 16.35万
  • 项目类别:
Effects of TNF-alpha and free radicals on apoptosis of bovine mamary epithlial cells
TNF-α和自由基对牛乳腺上皮细胞凋亡的影响
  • 批准号:
    155423-1998
  • 财政年份:
    1998
  • 资助金额:
    $ 16.35万
  • 项目类别:
    Discovery Grants Program - Individual
FREE RADICALS AND MITOCHONDRIA IN NEURONAL APOPTOSIS
神经元凋亡中的自由基和线粒体
  • 批准号:
    2750973
  • 财政年份:
    1998
  • 资助金额:
    $ 16.35万
  • 项目类别:
FREE RADICALS AND MITOCHONDRIA IN NEURONAL APOPTOSIS
神经元凋亡中的自由基和线粒体
  • 批准号:
    6152188
  • 财政年份:
    1998
  • 资助金额:
    $ 16.35万
  • 项目类别:
FREE RADICALS AND MITOCHONDRIA IN NEURONAL APOPTOSIS
神经元凋亡中的自由基和线粒体
  • 批准号:
    6330517
  • 财政年份:
    1998
  • 资助金额:
    $ 16.35万
  • 项目类别:
FREE RADICALS AND MITOCHONDRIA IN NEURONAL APOPTOSIS
神经元凋亡中的自由基和线粒体
  • 批准号:
    6477206
  • 财政年份:
    1998
  • 资助金额:
    $ 16.35万
  • 项目类别:
Free Radicals and Mitochondria in Neuronal Apoptosis
神经元凋亡中的自由基和线粒体
  • 批准号:
    6724061
  • 财政年份:
    1998
  • 资助金额:
    $ 16.35万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了